theres only 3 companies that produce it , Eli Lily, sanofi aventis and novo nordisk, they have fought aggressively through litigation in the past to prevent any insulin generic, or biosimilar to reach the market. they agreed amongst themselves to have whatever the cost they want without competing with each other.